You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I oropharyngeal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • +11 more
  • NavDx HPV ctDNA Testing
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

Recruiting
  • CDKN2A-p16 Positive
  • +5 more
  • Tucson, Arizona
    The University of Arizona Medical Center-University Campus
Mar 7, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal HPV-Positive Squamous Cell Carcinoma

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Oropharyngeal HPV-Positive Squamous Cell Carcinoma
  • Radiation Therapy
  • Atlanta, Georgia
  • +1 more
Jun 7, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Medical Chart Review
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Mar 15, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8, Clinical

Active, not recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8
  • +8 more
  • Durvalumab
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 7, 2021

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +3 more
  • Transoral Surgery
  • +8 more
  • New Brunswick, New Jersey
  • +2 more
Feb 16, 2022

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

HPV-associated Oropharyngeal Cancer

Recruiting
  • PREDICTIVE BIOMARKERS
  • +2 more
  • HPV-ASSOCIATED OROPHARYNGEAL CANCER
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Oct 19, 2023

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

Not yet recruiting
  • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
  • +15 more
  • Best Practice
  • +9 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 23, 2022

Active, not recruiting
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • +8 more
  • Cetuximab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute (UPCI)
Jan 26, 2023

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB

Recruiting
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • +2 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Birmingham, Alabama
  • +21 more
May 13, 2022

Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • PDS0101
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Papillomavirus Infections, Oropharyngeal Tumors Trial run by the NCI (E7 TCR)

Withdrawn
  • Papillomavirus Infections
  • Oropharyngeal Neoplasms
  • E7 TCR
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 21, 2020

Head and Neck Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma Trial in Philadelphia (Medical Device Usage and

Recruiting
  • Head and Neck Carcinoma
  • +15 more
  • Medical Device Usage and Evaluation
  • +5 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jun 8, 2021

Papillomavirus Infections, Oropharyngeal Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))

Terminated
Has Results
  • Papillomavirus Infections
  • Oropharyngeal Neoplasms
  • E7 T-Cell Receptor (TCR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 3, 2022

Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

Active, not recruiting
  • Laryngeal Cancer Stage II
  • +3 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
Sep 27, 2022